Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 92

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development

Rennebeck, Gabriela, Kleymenova, Elena V., Anderson, Rebecca, Yeung, Raymond S., Artzt, Karen, Walker, Cheryl L. · 1998 · Proceedings of the National Academy of Sciences

Abstract

Germline defects in the tuberous sclerosis 2 (TSC2) tumor suppressor gene predispose humans and rats to benign and malignant lesions in a variety of tissues. The brain is among the most profoundly affected organs in tuberous sclerosis (TSC) patients and is the site of development of the cortical tubers for which the hereditary syndrome is named. A spontaneous germline inactivation of the Tsc2 locus has been described in an animal model, the Eker rat. We report that the homozygous state of this mutation (Tsc2 Ek/Ek ) was lethal in mid-gestation (the equivalent of mouse E9.5–E13.5), when Tsc2 mRNA was highly expressed in embryonic neuroepithelium. During this period homozygous mutant Eker embryos lacking functional Tsc2 gene product, tuberin, displayed dysraphia and papillary overgrowth of the neuroepithelium, indicating that loss of tuberin disrupted the normal development of this tissue. Interestingly, there was significant intraspecies variability in the penetrance of cranial abnormalities in mutant embryos: the Long–Evans strain Tsc2 Ek/Ek embryos displayed these defects whereas the Fisher 344 homozygous mutant embryos had normal-appearing neuroepithelium. Taken together, our data indicate that the Tsc2 gene participates in normal brain development and suggest the inactivation of this gene may have similar functional consequences in both mature and embryonic brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.95.26.15629

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 39

  1. 10.1038/ng0294-193 · DOI · Paper page
  2. 10.1093/hmg/5.2.249 · DOI
  3. 10.1136/jmg.33.11.962 · DOI · Paper page
  4. 10.1073/pnas.91.24.11413 · DOI · Paper page
  5. 10.1038/ng0195-70 · DOI · Paper page
  6. M R Gomez Tuberous Sclerosis (Raven, 2nd Ed., New York, 1988).
  7. 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7 · DOI
  8. J Bjornsson, M P Short, D J Kwiatkowski, E P Henske Am J Pathol 149, 1201–1208 (1996).
  9. 10.1136/jmg.33.6.480 · DOI · Paper page
  10. 10.1073/pnas.93.17.9154 · DOI
  11. 10.1006/bbrc.1996.0183 · DOI
  12. 10.1074/jbc.270.27.16409 · DOI · Paper page
  13. R Wienecke, J C Maize, F Shoarinejad, W C Vass, J Reed, J S Bonifacino, J H Resau, J de Gunzburg, R S Yeung, J E DeClue Oncogene 13, 913–923 (1996).
  14. 10.1074/jbc.272.10.6097 · DOI · Paper page
  15. 10.3109/01913128009141432 · DOI
  16. 10.1007/BF00315012 · DOI
  17. E P Henske, B W Scheithauer, M P Short, R Wollmann, J Nahmias, M Hornigold, M van Slegtenhorst, C T Welsh, J Kwiatkowski Am J Hum Genet 59, 400–406 (1996).
  18. E P Henske, L Wessner, J Golden, B W Scheithauer, A Volkmeyer, P Zuang, A J Klein-Szanto, D J Kwiatkowski, R S Yeung Am J Path 151, 1639–1647 (1997).
  19. 10.1073/pnas.68.4.820 · DOI · Paper page
  20. 10.1038/189858b0 · DOI · Paper page
  21. R Eker, J Mossige, J V Johannessen, H Aars Diagn Histopathol 4, 99–110 (1981).
  22. 10.1016/S0022-5347(17)37087-8 · DOI
  23. 10.1016/0304-3835(94)90307-7 · DOI
  24. R S Yeung, C D Katsetos, A J Klein-Szanto Am J Path 151, 1477–1486 (1997).
  25. 10.1002/mc.2940140107 · DOI
  26. Y Kubo, H Mitani, O Hino Cancer Res 54, 2633–2635 (1994).
  27. 10.1073/pnas.90.1.327 · DOI · Paper page
  28. G H Xiao, F Jin, R S Yueng Oncogene 11, 81–87 (1995).
  29. , ed F M Ausubel (Wiley, New York Current Protocols in Molecular Biology, 1994).
  30. 10.1179/his.1989.12.3.169 · DOI · Paper page
  31. R Geist, D H Gutman Cell Growth Differ 6, 1477–1483 (1995).
  32. 10.1006/nbdi.1996.0011 · DOI
  33. 10.1073/pnas.93.24.14152 · DOI · Paper page
  34. 10.1016/0092-8674(93)90484-8 · DOI · Paper page
  35. C J Kemp, N R Drinkwater Cancer Res 49, 5044–5047 (1989).
  36. C J Moen, M Snoek, A A Hart, P Demant Oncogene 7, 563–566 (1992).
  37. M Obata, H Nishimori, K Ogawa, G H Lee Oncogene 13, 1599–1604 (1996).
  38. 10.1073/pnas.93.16.8460 · DOI · Paper page
  39. 10.1073/pnas.94.8.3990 · DOI

Cited by

See all 92

Metadata

Authors
Rennebeck, G., Kleymenova, E. V., Anderson, R., Yeung, R. S., Artzt, K., & Walker, C. L.
Venue
Proceedings of the National Academy of Sciences
Published
1998-12-22
Volume
95
Issue
26
Pages
15629-15634
ISSN
  • 0027-8424
  • 1091-6490
Cited by
92
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. https://app.cochat.ai/papers/10.1073/pnas.95.26.15629
The paper
Rennebeck, G., Kleymenova, E. V., Anderson, R., Yeung, R. S., Artzt, K., & Walker, C. L. (1998). Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.95.26.15629

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.